Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ptc Therapeutics (PTCT) Accumulated Depreciation & Amortization (2016 - 2025)

Ptc Therapeutics (PTCT) has 13 years of Accumulated Depreciation & Amortization data on record, last reported at $33.4 million in Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization fell 34.94% year-over-year to $33.4 million; the TTM value through Dec 2024 reached $33.4 million, down 34.94%, while the annual FY2024 figure was $33.4 million, 34.94% down from the prior year.
  • Accumulated Depreciation & Amortization reached $33.4 million in Q4 2024 per PTCT's latest filing, down from $51.3 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $51.3 million in Q4 2023 and bottomed at $18.1 million in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $33.4 million, with a median of $33.4 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 43.87% in 2020, then skyrocketed 50.44% in 2021.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $18.1 million in 2020, then surged by 50.44% to $27.2 million in 2021, then soared by 37.52% to $37.4 million in 2022, then surged by 37.21% to $51.3 million in 2023, then tumbled by 34.94% to $33.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $33.4 million in Q4 2024, $51.3 million in Q4 2023, and $37.4 million in Q4 2022.